Skip to content

Application of Ultrasound-guided internal branch of superior laryngeal nerve block combined with transversus abdominis plane block in ERAS of patients undergoing laparoscopic surgery

Application of Ultrasound-guided internal branch of superior laryngeal nerve block combined with transversus abdominis plane block in ERAS of patients undergoing laparoscopic surgery

Status
Recruiting
Phases
Early Phase 1
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2000038355
Enrollment
Unknown
Registered
2020-09-21
Start date
2020-09-09
Completion date
Unknown
Last updated
2021-05-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Rapid recovery of patients undergoing laparoscopic surgery

Interventions

group A:Bilateral ibSLN block (2% lidocaine 3ml) + TAP block, sufentanil induction dose of 0.4ug/kg
group B:Bilateral ibSLN block (2% lidocaine 3ml) + TAP block, sufentanil induction dose of 0.2ug/kg
group C:Bilateral ibSLN block (2% lidocaine 3ml) + TAP block, sufentanil induction dose of 0ug/kg
group D:Bilateral ibSLN block (Physiological saline 3ml) + TAP block, sufentanil induction dose of 0.4ug/kg

Sponsors

Affiliated Hospital of Guilin Medical University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 65 Years

Inclusion criteria

Inclusion criteria: 1.Patients scheduled for laparoscopic surgery; 2.American Society of Anesthesiologist's (ASA) grade I to III; 3.Age 18-65 years old, height 145-185cm, weight 45-80kg; 4.Educational level above primary school; 5.Sign the informed consent form.

Exclusion criteria

Exclusion criteria: 1.Participated in other clinical trials within 4 weeks before operation; 2.There are serious heart, lung, liver, kidney and other organ dysfunction; 3.History of neurological and mental illness, long-term use of sedative drugs; 4.Patients have severe aphasia, visual and hearing impairment, severe motor impairment, and are unable to cooperate with the examination; 5.Pregnant or lactating women; 6.Patients with motion sickness and allergy to ropivacaine; 7.The amount of intraoperative blood loss is greater than that of 500ml; 8.Enlarge surgical incision during operation.

Design outcomes

Primary

MeasureTime frame
Usage of sufentanil;Usage of remifentanil;SPO2;heart rate;Blood pressure;

Secondary

MeasureTime frame
Anesthesia time;Blood pressure;Sore throat;imes of nausea and vomiting;NRS pain score at 3, 6, 12, 24 and 48 hours after operation;Types and doses of analgesics used in wards;Other special circumstances;

Countries

China

Contacts

Public ContactZhang Xu

Affiliated Hospital of Guilin Medical University

zhangxu918@aliyun.com+86 13367638918

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026